WHILE LAUDING EXCELLENT GROWTH FOR THE SECOND QUARTER, executives at Labcorp and Quest Diagnostics also expressed concern over the Protecting Access to Medicare Act (PAMA), which was passed by Congress in 2014 and which continues to cause uncertainty as full implementation is repeatedly delayed. PAMA requires Medicare to base its Clinical Laboratory Fee Schedule (CLFS) […]
Quest, Labcorp Discuss PAMA and M&A with Investors
The companies report stellar Q2 financial results, new acquisitions, and future strategies
- By Mark Terry
- > From the Volume XXXII, No. 13 - September 15, 2025 Issue
- Tags: ACLS, American Clinical Laboratory Association, Biopharma, BioReference Health, clfs, Clinical Laboratory Fee Schedule, Community Health Systems, Incyte Diagnostics, Jim Davis, Julia Wang, LabCorp, LaunchPad, LifeLabs, Medicare, PAMA, Protecting Access to Medicare Act of 2014, Quest Diagnostics, Sam Samad, UHealth, University of Miami Health System
